Friday, February 8, 2013

Health Industry Leader MusclePharm Corp. (MSLP) Looking Even Healthier


A recent article in Seeking Alpha (http://dtg.fm/hX7G) offers a positive look at MusclePharm, a Colorado-based maker of nutritional supplements for athletes and active health-conscious consumers, calling it a new star on the horizon. MusclePharm has been garnering attention since famed entrepreneur and investor Dr. Phillip Frost put $1.4 million into the company in late January, driving a major jump in share price. The article provides a good overview of the industry, the company and its products, as well as its growth strategy.

MusclePharm stands out in the rapidly growing world of nutritional supplements through its emphasis on science-based testing and formulation. The company’s Sports Science Center Research Institute in Colorado maintains a team of doctors and scientists that use an advanced 6-stage research protocol, together with extensive field testing by professional athletes from the National Football League, Mixed Martial Arts, and Major League Baseball, to formulate a full line of nutritional supplements 100% free of banned substances. Their clinic can perform bone scans, blood work, ultrasounds, muscle and fat evaluations, kidney and liver tests, cortisol tests, reaction-time testing, and much more, to provide a scientific basis to their formulations. It’s a key reason that MusclePharm fans are so devoted.

MusclePharm’s growth strategy, as pointed out in the Seeking Alpha article, is to continue increasing domestic and international market penetration, pushing brand awareness through endorsements and sponsorships, while improving operations to increase margins. The company wants to be known as the athlete’s company, targeting both professional and amateur athletes, and already has numerous athletic contacts to support its drive.

The article concludes with a reference to a European distributor who had indicated how popular MusclePharm products are, especially in the U.S. and Latin America, and how international sales will be a significant part of MusclePharm’s sales for the foreseeable future.

For additional information on MusclePharm, visit www.MusclePharm.com

About MissionIR

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Sign up for “The Mission Report” at www.MissionIR.com

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html